Variantyx Revenue and Competitors
Estimated Revenue & Valuation
- Variantyx's estimated annual revenue is currently $36.4M per year.
- Variantyx's estimated revenue per employee is $193,750
- Variantyx's total funding is $80.5M.
Employee Data
- Variantyx has 188 Employees.
- Variantyx grew their employee count by -4% last year.
Variantyx's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | COO | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | VP Sales | Reveal Email/Phone |
6 | VP Systems and Security | Reveal Email/Phone |
7 | VP Marketing | Reveal Email/Phone |
8 | VP Customer Support & Laboratory Services | Reveal Email/Phone |
9 | VP Information Systems | Reveal Email/Phone |
10 | Director Financial Planning and Analysis | Reveal Email/Phone |
Variantyx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Variantyx?
Genomic Unity® testing uses a single method for detection of multiple types of variants to provide one, unified clinical report. PCR-free whole genome sequencing is paired with in-silico analysis to identify small sequence changes, large structural variants, mitochondrial variants and tandem repeat expansions within a single sample. A complete analysis can be ordered directly, or a more targeted analysis can be selected followed by reflexing up to the complete analysis in case no initial results are identified. Learn more at www.variantyx.com/diagnostic-testing/.
keywords:N/A
$80.5M
Total Funding
188
Number of Employees
$36.4M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Variantyx News
Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, completed an investment in Variantyx Inc., a Framingham, MA-based provider of advanced diagnostics and personalized treatment recommendations for oncology patients’ based on their unique genetic makeup. ...
Haim Neerman, CEO of Variantyx. For medical practitioners expertly trained in the scientific methods of discovery, having a young patient with serious health complications from an undiagnosed condition is about as somber and frustrating as it gets. These feelings are only magnified for parents ...
BOSTON--(BUSINESS WIRE)--Mar 15, 2021-- Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inhe ...
Other Companies in Framingham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 189 | 8% | N/A |
#2 | $31.9M | 200 | N/A | N/A |
#3 | $31.6M | 204 | -2% | N/A |
#4 | $33.4M | 217 | -1% | N/A |
#5 | $33.3M | 221 | 0% | $46M |